HCPLive Network

BCIS Myocardial Jeopardy Score Predicts Post-PCI Death

 
FRIDAY, Jan. 18 (HealthDay News) -- The British Cardiovascular Intervention Society myocardial jeopardy score (BCIS-JS) predicts mortality after percutaneous coronary intervention (PCI), according to research published in the Jan. 15 issue of The American Journal of Cardiology.

Kalpa De Silva, M.B.B.S., of King's College London, and colleagues conducted a retrospective study involving 660 patients who underwent PCI with previous left ventricular function assessment. Of these, 221 patients had previously undergone coronary artery bypass grafting (CABG). Blinded observers calculated the BCIS-JS before (BCIS-JSPRE) and after (BCIS-JSPOST) PCI, and the extent of revascularization was quantified using the revascularization index (RI; RI = [BCIS-JSPRE − BCIS-JSPOST]/BCIS-JSPRE).

The researchers found that both BCIS-JSPRE and BCISJSPOST scores were directly related to all-cause mortality (hazard ratios [HRs], 2.96 and 4.02, respectively). Other independent predictors of mortality included having a RI of less than 0.67 (HR, 1.99), left ventricular dysfunction (HR, 2.03), and renal impairment (HR, 3.75), in multivariate analysis.

"The present findings have demonstrated that the BCIS-JS has prognostic significance in a contemporary cohort of patients undergoing PCI. Higher BCIS-JSPRE and BCIS-JSPOST scores are associated with increased mortality and the BCIS-JS-derived RI is an independent predictor of mortality," the authors write. "Our findings confirm that the BCIS-JS is a highly reproducible, valid angiographic scoring tool and supports its use in risk stratification and guiding PCI in patients with coronary artery disease, including patients who have undergone previous CABG."
 

Abstract
Full Text (subscription or payment may be required)


Copyright © 2013 HealthDay. All rights reserved.
 
 

Further Reading
Even though the active ingredient in marijuana can be associated with memory impairment, it may slow or halt Alzheimer’s disease.
The costs of Medicare associated with Sovaldi (sofosbuvir), an emerging hepatitis C drug, will vary depending on how many people are given the treatment, a blog in Health Affairs found.
For patients with cancer, factors associated with late admission to hospice have been identified, according to a study published online Aug. 25 in the Journal of Clinical Oncology.
Revised guidelines recommend athletes to drink when they are thirsty and to supplement post-training fluids with “recovery foods.”
Gastroparesis, or delayed gastric emptying, remains misunderstood despite rising prevalence, according to a news release from the International Foundation for Functional Gastrointestinal Disorders (IFFGD), a nonprofit research and education organization addressing issues surrounding gastrointestinal and motility disorders.
The European Commission (EU) has granted Bristol-Myers Squibb’s Daklinza (daclatasvir) approval for an all-oral drug regimen for the treatment of four genotypes of chronic hepatitis C infection.
A new multi-step skin testing protocol effectively determines the presence of isosulfan blue allergy, according to a study conducted by researchers at the University of Virginia.
More Reading